Relapsing Polychondritis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-05-13
Clinical Trial Update: Tocilizumab for Relapsing Polychondritis [Phase 2]
A Phase 2 clinical trial evaluating tocilizumab for Relapsing Polychondritis has been withdrawn.